1. China Stocks

  2. •

    Consumer services

  3. •

    Other consumer services
Beauty Farm Medical & Health Industry, Inc.

Beauty Farm Medical & Health Industry, Inc.

2.02
EUR
+0.02
(+1.00%)
671.93MMarket Cap
Mar 31Next Earn
Beauty Farm Medical & Health Industry, Inc.
FRA:XC5
(Frankfurt Stock Exchange)

Recent

price

2.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
CNY
6.09
6.52
7.72
7.09
9.38
11.2
13.08
- -
Revenue per Share
0.61
0.65
0.84
0.45
0.94
0.99
1.38
- -
Basic EPS, GAAP
1.54
2.66
2.33
1.05
2.04
2.97
4.06
- -
Free Cash Flow per Basic Share
0.35
0.46
0.35
0.89
0.38
0.49
0.53
- -
Dividend per Share
0.21
0.61
1.12
0.82
3.39
4.01
4.35
4.35
Book Value per Share
-0.89
-0.54
-0.12
-0.39
2.13
-0.25
-0.11
-0.11
Tangible Book Value per Share
231
231
231
231
229
230
229
233
Basic Weighted Avg Shares
1,405
1,503
1,781
1,635
2,145
2,572
3,001
- -
Sales/Revenue/Turnover
14.12
13.56
14.3
7.97
12.4
12.04
15
- -
Operating Margin (%)
224
259
275
297
332
383
405
- -
Depreciation Expense
140
151
193
103
216
228
318
- -
Net Income, GAAP
17.99
19.28
18.33
15.28
20.17
20.58
24.39
- -
Effective Tax Rate (%)
9.99
10.04
10.86
6.3
10.05
8.88
10.58
- -
Profit Margin (%)
-671
-602
-544
-661
-116
-553
-52
-52
Working Capital
436
368
352
375
394
490
995
995
LT Debt
53
141
263
203
834
975
1,067
1,067
Total Equity
- -
25.77
29.98
16.11
20.02
14.92
15.62
- -
Return on Invested Capital (%)
- -
26.7
27.66
15.48
20.79
14.59
15.69
- -
Return on Capital (%)
- -
160.41
97.17
46.23
43.54
26.16
32.29
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
240
239
299
LT Borrowings
130
212
643
LT Finance Leases
360
329
353
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
236
236
235
Market Capitalization
3,583
4,514
5,521

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
2,186
2,327
2,858
Cash, Cash Equivalents & STI
1,831
1,997
2,542
Accounts Receivable, Net
49
33
51
Inventories
152
150
108
Total Current Liabilities
2,739
2,764
2,910
Payables & Accruals
- -
- -
- -
ST Debt
240
239
299
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
80.19%
9.4%
Free Cash Flow
- -
21.75%
36.57%
Net Income, GAAP
- -
27.11%
39%
Sales/Revenue/Turnover
- -
15.6%
16.65%
Total Cash Common Dividend
- -
21.66%
8.69%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
2,145
2024
- -
- -
2,572
2025
- -
- -
3,001

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.94
2024
- -
- -
0.99
2025
- -
- -
1.38

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.38
2024
- -
- -
0.49
2025
- -
- -
0.53
Similar Companies
Booking Holdings Inc. Common Stock (NASDAQ:BKNG)
Indian Railway Catering & Tourism Corp. Ltd. (NSE:IRCTC)
Expedia Group, Inc. (NASDAQ:EXPE)
Peloton Interactive, Inc. (NASDAQ:PTON)
Gur-Sel Turizm Tasimacilik Ve Servis Ticaret A.S. (BIST:GRSEL)
akippa Inc. (TSE:627A)
Business
Beauty Farm Medical and Health Industry Inc. (2373.HK) operates as an investment holding company providing comprehensive beauty and health management services in China through its "dual beauty + dual wellness" model, encompassing traditional beauty services; aesthetic medical services including skin texture management, skin tone management, integrated injection services, energy-based treatments, body sculpting, and surgical aesthetics; and subhealth assessment and intervention services such as chronic disease prevention, metabolic disease management, and women's reproductive health. The company offers these services via a diversified brand portfolio featuring flagship Beauty Farm with over 300 stores delivering facial beauty treatments and healthcare using international products and standardized processes; premium professional beauty brand Palaispa providing high-end body care with European techniques and skincare; AI-powered wellness brand Naturade rooted in traditional Chinese medicine offering one-stop beauty, wellness, and pain management primarily in the Greater Bay Area with over 130 stores; aesthetic medical franchise CellCare specializing in full-service treatments across 27 stores in tier-one cities; subhealth brand Neology with personalized functional medicine solutions in 11 urban stores; and premium salon skincare brand Siyanli focused on tech-driven results across over 180 stores in nearly 50 cities. Founded in 1993 and headquartered in Shanghai, Beauty Farm maintains an extensive national network of 734 stores across more than 100 cities in over 30 provinces and regions, serving over one million customers annually and targeting urban women seeking high-quality beauty, wellness, and medical services. Recent developments include listing on the Hong Kong Stock Exchange's Main Board in January 2023; acquiring a 70% stake in Naturade in 2024 followed by increasing ownership to 90% in 2025; and strategically purchasing 100% of Siyanli for RMB1.25 billion in October 2025, the largest M&A deal in China's beauty service industry that year, expanding its store count, integrating 60,000 active members to boost direct store membership by over 44%, and solidifying its top-three market position alongside Beauty Farm and Naturade per Frost & Sullivan data.